Yes, Start a High-Intensity Statin
With an ABI of 0.9, you have peripheral artery disease (PAD) and should start high-intensity statin therapy immediately. An ABI ≤0.90 confirms the diagnosis of PAD, and lipid-lowering therapy with high-intensity statins is a cornerstone of guideline-directed medical therapy to reduce major adverse cardiovascular events (MACE) and major adverse limb events (MALE) 1.
Why This Matters
Your ABI of 0.9 places you at the diagnostic threshold for PAD, which significantly increases your risk of:
- Myocardial infarction
- Stroke
- Cardiovascular death
- Limb complications including amputation 1
The 2024 ACC/AHA/Multisociety PAD Guidelines explicitly state that effective medical therapies for PAD patients must include lipid-lowering with high-intensity statin therapy 1. This is not optional—it's a fundamental component of preventing both cardiovascular events and limb-related complications.
The Evidence Supporting Statin Therapy in PAD
Functional Benefits Beyond Lipid Lowering
Statins provide benefits in PAD patients that extend beyond cholesterol reduction:
PAD patients on statins experience significantly less annual decline in walking performance compared to non-users, including preservation of usual-pace walking velocity (0.002 vs. -0.024 m/s/year, p=0.013) and rapid-pace walking velocity (-0.006 vs. -0.042 m/s/year, p=0.006) 2
Short-term atorvastatin therapy significantly delays decline in walking speed and improves lower-extremity function in PAD patients 3
These functional benefits are clinically meaningful for maintaining quality of life and independence
Mortality Reduction
Statin use is associated with approximately 50% lower all-cause mortality (HR 0.51,95% CI 0.30-0.86) and 64% lower cardiovascular mortality (HR 0.36,95% CI 0.14-0.89) in PAD patients 4. This mortality benefit appears most pronounced in patients with elevated inflammatory markers.
Additional Considerations for LDL-C Goals
If you're already on maximally tolerated statin therapy but your LDL-C remains ≥70 mg/dL, the 2024 guidelines recommend adding:
Complete Medical Therapy Package
Beyond statins, your PAD diagnosis (ABI ≤0.90) warrants:
- Single antiplatelet therapy (clopidogrel preferred over aspirin) to reduce MACE risk 1, 5
- Blood pressure control with antihypertensive therapy
- Smoking cessation if applicable (critical for PAD outcomes)
- Diabetes management with GLP-1 receptor agonists or SGLT2 inhibitors if diabetic 5
Common Pitfalls to Avoid
Don't wait for symptoms to develop. Even asymptomatic PAD (which you may have) requires aggressive medical therapy. Only 10% of PAD patients present with classic claudication symptoms 5, so the absence of leg pain doesn't diminish the need for treatment.
Don't assume a "borderline" ABI (0.9) is less serious. An ABI of exactly 0.9 meets the diagnostic threshold for PAD and carries the same cardiovascular risk as lower values 6, 7.
Don't delay statin initiation. The functional decline in PAD is progressive, and early statin therapy helps preserve walking ability and reduces mortality risk 2, 4.